REPLIGEN CORP - COMMON STOCK (RGEN)

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
43,536,727
Share change
-1,403,644
Total reported value
$4,026,405,029
Put/Call ratio
182%
Price per share
$92.50
Number of holders
294
Value change
-$116,718,905
Number of buys
135
Number of sells
148

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2019

As of 31 Dec 2019, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 294 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,536,727 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Invesco Ltd., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Conestoga Capital Advisors, LLC, FRED ALGER MANAGEMENT, LLC, 12 West Capital Management LP, FEDERATED HERMES, INC., and MACQUARIE GROUP LTD. This page lists 294 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.